NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -52.7% | 20,449 | -33.3% | 0.00% | – |
| Q2 2023 | $55 | +17.0% | 30,673 | -2.6% | 0.00% | – |
| Q1 2023 | $47 | -4.1% | 31,491 | -10.0% | 0.00% | -100.0% |
| Q4 2022 | $49 | -100.0% | 34,983 | -29.6% | 0.00% | -50.0% |
| Q3 2022 | $137,000 | -64.8% | 49,684 | -40.0% | 0.00% | -60.0% |
| Q2 2022 | $389,000 | -14.3% | 82,838 | -11.3% | 0.01% | -16.7% |
| Q1 2022 | $454,000 | -7.0% | 93,406 | +14.9% | 0.01% | +20.0% |
| Q4 2021 | $488,000 | +607.2% | 81,297 | +691.8% | 0.01% | +400.0% |
| Q3 2021 | $69,000 | -79.4% | 10,268 | -75.4% | 0.00% | -75.0% |
| Q2 2021 | $335,000 | +144.5% | 41,719 | +205.5% | 0.00% | +100.0% |
| Q1 2021 | $137,000 | -74.8% | 13,658 | -46.1% | 0.00% | -85.7% |
| Q2 2020 | $543,000 | – | 25,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |